Cetuximab-Associated Crescentic Diffuse Proliferative Glomerulonephritis

Cetuximab-induced nephrotoxicity is very rare, occurring in less than 1% of colorectal cancer patients and not defined in other populations. We report a rare case of crescentic diffuse proliferative glomerulonephritis (GN) that developed in close temporal association with cetuximab treatment. A 65-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Manthri, Sukesh, Bandaru, Sindhura, Chang, Anthony, Hudali, Tamer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733935/
https://www.ncbi.nlm.nih.gov/pubmed/29348949
http://dx.doi.org/10.1155/2017/7964015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733935/
https://www.ncbi.nlm.nih.gov/pubmed/29348949
http://dx.doi.org/10.1155/2017/7964015

Ejemplares similares